C-reactive protein (CRP) is a non-specific biomarker of inflammation. Recent research has
shown that inflammation is an important step in the genesis of atherosclerosis, and is …

Atherosclerosis is considered a to be multifactorial disease driven by inflammatory reactions.
The process of inflammation also contributes to the pathogenesis of acute atherothrombotic …

Background: Inflammation is pivotal in all phases of atherosclerosis. Among the numerous
inflammatory biomarkers, the largest amount of published data supports a role for C-reactive …

C-reactive protein (CRP) is the first acute phase protein that has been described in the
literature. It is phylogenetically ancient and-with serum amyloid P-belongs to proteins named …

Inflammation appears to be pivotal in all phases of atherosclerosis from the fatty streak
lesion to acute coronary syndromes. An important downstream marker of inflammation is C …

The complex relationship between the inflammatory response and vascular injury and repair
is of major importance to the pathogenesis of cardiovascular disease. CRP is not only a …

Inflammatory processes play a pivotal role in the pathogenesis of atherosclerosis and
mediate many of the stages of atheroma development from initial leukocyte recruitment to …

C-reactive protein (CRP) is an acute-phase protein, which has been used in clinical practice
as a non specific marker of inflammation. Many studies have shown that CRP is associated …

Despite progress in the prevention of cardiovascular disease, a significant proportion of first
cardiovascular events occurs among individuals without traditional risk factors. Given the …

A large body of literature supports the idea that inflammation plays a pivotal role in all
phases of atherosclerosis, from the fatty streak lesion formation to the acute coronary event …